SGMO Wutah pendapatan kuartal marang kuartal sangamo.com

Lambang korporat lan logo Sangamo (SGMO)

Sangamo Therapeutics (SGMO) operates a business that is independent of economic fluctuations, as demand for the treatment of genetic pathologies remains stable. The relative change in quarterly revenue confirms this trend, with the 87.80 metric serving as the target level. Revenues currently rely on partner payments while testing continues. Patents for the ZFP platform provide the company with significant pricing power.

SGMO (Sangamo) riwayat Wutah pendapatan triwulanan saka 04.07.2022 nganti 09.05.2026

Rincian analitis lan laporan data perusahaan Sangamo (SGMO)

Analisis kabeh metrik perusahaan:Sangamo - SGMO
Produk sing diprodhuksi Sangamo Therapeutics Inc.

Quarterly revenue growth for Sangamo Therapeutics on the GURU.Markets platform reflects the effectiveness of the company's patent portfolio commercialization. This indicator measures the percentage change in sales volume between the current and previous quarters, capturing the speed of business scaling. The calculation model compares current receipts with historical data, identifying the impact of licensing agreements with pharma behemoths on cash flow. Stable dynamics confirm the fundamental resilience of the monetization model for scientific discoveries.

Karo sapa Sangamo Therapeutics saingan

TEM - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal qiagen.com QGEN|IONS: Wutah pendapatan triwulanan|Repligen Corp - Tambahing pendapatan triwulanan|RNA (Avidity Corp) - Wutah pendapatan triwulanan|CRISPR Therapeutics Corp - Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal genedx.com (WGS)|Wutah pendapatan triwulanan ultragenyx.com (RARE)|Wutah pendapatan triwulanan BEAM (Beam Therapeutics Inc)|Sarepta Therapeutics Inc (SRPT) - Tingkat wutah pendapatan sajrone kuartal|twistbioscience.com - Wutah pendapatan triwulanan|10x Genomics, Inc. - Owah-owahan dodolan kuartal marang kuartal|NTLA (Intellia Corp) - Wutah dodolan triwulanan|Wutah dodolan triwulanan stoketherapeutics.com|Wutah dodolan triwulanan BLFS|Wutah dodolan triwulanan Wave Life Sciences Corp (WVE)|Wutah pendapatan triwulanan MAZE|Tingkat wutah dodolan sajrone kuartal Sionna Therapeutics Inc|Wutah pendapatan kuartal marang kuartal Prime Medicine Corp PRME|tayshagtx.com (TSHA) - Tingkat wutah pendapatan sajrone kuartal|QURE - Wutah pendapatan kuartal marang kuartal|MeiraGTx Holdings (MGTX) - Wutah dodolan triwulanan|Regenxbio (RGNX) - Wutah pendapatan kuartal marang kuartal|SLDB - Tingkat wutah dodolan sajrone kuartal|OCGN (Ocugen Inc) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal PACB|Wutah pendapatan kuartal marang kuartal Benitec (BNTC)|Design Therapeutics Inc - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Rocket Pharma RCKT|Wutah pendapatan triwulanan 4DMT FDMT|LXEO - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Korro Bio Inc.|EDIT: Wutah pendapatan triwulanan|SLN - Tingkat wutah dodolan sajrone kuartal|PRQR (ProQR Therapeutics) - Wutah pendapatan triwulanan|codexis.com (CDXS) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan NAUT|Wutah dodolan triwulanan Metagenomi, Inc. MGX|Wutah pendapatan kuartal marang kuartal Precision BioSciences DTIL|Tambahing pendapatan triwulanan GBIO|BOLD - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Wutah pendapatan kuartal marang kuartal|RXi Pharmaceuticals - Tambahing pendapatan triwulanan|MBIO (Mustang Bio) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal RNAZ (transcodetherapeutics.com)|Wutah pendapatan kuartal marang kuartal Bionano (BNGO)|Applied DNA Sciences - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Tingkat wutah pendapatan sajrone kuartal|omegatherapeutics.com - Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Singular Genomics Systems Inc (OMIC)|RGLS: Wutah pendapatan triwulanan|Syros Pharmaceuticals, Inc (SYRS) - Wutah pendapatan triwulanan|TBIO (telesisbio.com) - Wutah pendapatan triwulanan|TCON: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Unity Biotechnology, Inc (UBX)